Physician profile
Daniel E Orozco
NPI 1497949028
$809.25
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $500 · 2020: $184 · 2022: $102 · 2023: $23.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $23.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $23.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $241.25 | 2020-2022 | |
| Osteomed LLC | $169.78 | 2019-2020 | |
| Smith+Nephew, INC. | $138.55 | 2019 | |
| Sandoz INC. | $137.25 | 2019 | |
| Zyla Life Sciences, INC. | $67.10 | 2019 | |
| Paratek Pharmaceuticals, INC. | $23.29 | 2023 | Nuzyra |
| Melinta Therapeutics, LLC | $19.56 | 2019 | |
| Medtronic Vascular, INC. | $12.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Orozco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.